Re: Nader Al Nakouzi, Sylvestre le Moulec, Laurence Albigès, et al. Cabazitaxel Remains Active in Patients Progressing after Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. Eur Urol. in press. http://dx.doi.org/10.1016/j.eururo.2014.04.015

Publication

Publication

European Urology : Official Journal of the European Association of Urology , Volume 66 - Issue 4